Evidence map›Paper›PMID 37702280›Full record

ArticleJournal of the American Heart Association2023

Prevalence, Associated Factors, and Echocardiographic Estimation of Left Atrial Hypertension in Patients With Atrial Fibrillation.

Yasuhiro Mukai, Koki Nakanishi, Masao Daimon, Kentaro Iwama, Yuriko Yoshida, Kazutoshi Hirose, Yuko Yamamoto, Hikari Seki, Tomoko Nakao, Tsukasa Oshima and 8 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 5 institutions in 1 country.

Yasuhiro MukaiDepartment of Cardiovascular Medicine The University of Tokyo Tokyo Japan.
Koki NakanishiDepartment of Cardiovascular Medicine The University of Tokyo Tokyo Japan.ORCID 0000-0002-5787-8004
Masao DaimonDepartment of Cardiovascular Medicine The University of Tokyo Tokyo Japan.ORCID 0000-0002-7616-3477
Kentaro IwamaDepartment of Cardiovascular Medicine The University of Tokyo Tokyo Japan.ORCID 0000-0002-5673-5829
Yuriko YoshidaDepartment of Cardiovascular Medicine The University of Tokyo Tokyo Japan.
Kazutoshi HiroseDepartment of Cardiovascular Medicine The University of Tokyo Tokyo Japan.ORCID 0000-0002-7084-9830
Yuko YamamotoDepartment of Cardiovascular Medicine The University of Tokyo Tokyo Japan.
Hikari SekiDepartment of Cardiovascular Medicine The University of Tokyo Tokyo Japan.
Tomoko NakaoDepartment of Cardiovascular Medicine The University of Tokyo Tokyo Japan.ORCID 0000-0002-4285-1888
Tsukasa OshimaDepartment of Cardiovascular Medicine The University of Tokyo Tokyo Japan.
Takumi MatsubaraDepartment of Cardiovascular Medicine The University of Tokyo Tokyo Japan.
Yu ShimizuDepartment of Cardiovascular Medicine The University of Tokyo Tokyo Japan.ORCID 0009-0001-0167-5371
Gaku OguriDepartment of Cardiovascular Medicine The University of Tokyo Tokyo Japan.
Toshiya KojimaDepartment of Cardiovascular Medicine The University of Tokyo Tokyo Japan.ORCID 0009-0000-1825-1228
Eriko HasumiDepartment of Cardiovascular Medicine The University of Tokyo Tokyo Japan.
Katsuhito FujiuDepartment of Cardiovascular Medicine The University of Tokyo Tokyo Japan.ORCID 0000-0002-1889-9291
Hiroyuki MoritaDepartment of Cardiovascular Medicine The University of Tokyo Tokyo Japan.
Issei KomuroDepartment of Cardiovascular Medicine The University of Tokyo Tokyo Japan.ORCID 0000-0002-0714-7182
The University of Tokyo · JPShimizu (Japan) · JPTokyo Fuji University · JPTokyo Gakugei University · JPYamamoto Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Elevated left atrial (LA) pressure predisposes individuals to the initiation and persistence of atrial fibrillation (AF), and LA hypertension is associated with AF recurrence after catheter ablation (CA). However, the exact frequency and factors associated with LA hypertension are unknown, and its noninvasive estimation is challenging. This study aimed to investigate the prevalence and determinants of LA hypertension in patients with AF who underwent first CA. Methods and Results We examined 183 patients with AF who underwent conventional and speckle-tracking echocardiography before CA to assess LA size, reservoir strain, and stiffness. Direct LA pressure was measured at the time of CA, and LA hypertension was defined as mean LA pressure >15 mm Hg. Thirty-three (18.0%) patients exhibited LA hypertension. Patients with LA hypertension had a significantly larger LA volume index (40.2 [28.4-52.1] versus 34.1 [26.9-42.4] mL/m

Indexed as

Atrial FibrillationHypertensionEchocardiographyHeart AtriaHumansPrevalenceatrial fibrillationC‐reactive proteinleft atrial hypertensionleft atrial stiffnessspeckle‐tracking echocardiographywaist circumference

Identifiers

PMID37702280
PMCPMC10547270
OpenAlexW4386705013

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.